MX377657B - "composicion farmaceutica que contiene un derivado de imidazolina" - Google Patents
"composicion farmaceutica que contiene un derivado de imidazolina"Info
- Publication number
- MX377657B MX377657B MX2018009742A MX2018009742A MX377657B MX 377657 B MX377657 B MX 377657B MX 2018009742 A MX2018009742 A MX 2018009742A MX 2018009742 A MX2018009742 A MX 2018009742A MX 377657 B MX377657 B MX 377657B
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical composition
- composition containing
- imidazoline derivative
- containing imidazoline
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
En la presente invención se proporciona una composición farmacéutica que contiene un derivado de imidazolina. En términos particulares, la composición farmacéutica proporcionada en la presente invención contiene (S)-4-(3-(4-(2,3-dihidroxipropoxi)fenil)-4,4-dimetil-5-carbonil-2-tioxoimidazolidin-1-il)-2-(trifluorometil) benzonitrilo y éter de celulosa; la composición tiene buena estabilidad, velocidad de disolución y biodisponibilidad.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610093969 | 2016-02-19 | ||
| PCT/CN2017/073868 WO2017140253A1 (zh) | 2016-02-19 | 2017-02-17 | 一种含有咪唑啉类衍生物的药物组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018009742A MX2018009742A (es) | 2018-11-09 |
| MX377657B true MX377657B (es) | 2025-03-11 |
Family
ID=59624768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018009742A MX377657B (es) | 2016-02-19 | 2017-02-17 | "composicion farmaceutica que contiene un derivado de imidazolina" |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10588978B2 (es) |
| EP (1) | EP3417857B1 (es) |
| JP (1) | JP6968075B2 (es) |
| KR (1) | KR20180109991A (es) |
| CN (1) | CN107530325B (es) |
| AU (1) | AU2017220970B2 (es) |
| BR (1) | BR112018015370A2 (es) |
| CA (1) | CA3014088A1 (es) |
| MX (1) | MX377657B (es) |
| RU (1) | RU2749135C2 (es) |
| TW (1) | TWI732822B (es) |
| WO (1) | WO2017140253A1 (es) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070072888A (ko) * | 2004-10-25 | 2007-07-06 | 니뽄 다바코 산교 가부시키가이샤 | 용해성 및 안정성이 개선된 고형 제제 및 그의 제조 방법 |
| PL2389164T3 (pl) * | 2009-01-21 | 2015-01-30 | Hoffmann La Roche | Kompozycje farmaceutyczne zawierające prolek inhibitora polimerazy HCV |
| RU2453315C2 (ru) * | 2010-08-17 | 2012-06-20 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая композиция для лечения аллергических заболеваний |
| SI2894151T1 (sl) * | 2012-09-04 | 2021-01-29 | Shanghai Hengrui Pharmaceutical Co. Ltd. | Imidazolinski derivati, postopki za njihovo pripravo in njihove uporabe v medicini |
| CN105030685B (zh) * | 2015-07-21 | 2018-02-27 | 福格森(武汉)生物科技股份有限公司 | 一种恩杂鲁胺固体分散体口服制剂 |
-
2017
- 2017-02-17 EP EP17752685.2A patent/EP3417857B1/en active Active
- 2017-02-17 AU AU2017220970A patent/AU2017220970B2/en not_active Ceased
- 2017-02-17 KR KR1020187025162A patent/KR20180109991A/ko not_active Ceased
- 2017-02-17 MX MX2018009742A patent/MX377657B/es active IP Right Grant
- 2017-02-17 JP JP2018537445A patent/JP6968075B2/ja not_active Expired - Fee Related
- 2017-02-17 CA CA3014088A patent/CA3014088A1/en active Pending
- 2017-02-17 CN CN201780001360.5A patent/CN107530325B/zh active Active
- 2017-02-17 RU RU2018129762A patent/RU2749135C2/ru active
- 2017-02-17 BR BR112018015370-2A patent/BR112018015370A2/pt active Search and Examination
- 2017-02-17 US US16/077,610 patent/US10588978B2/en not_active Expired - Fee Related
- 2017-02-17 WO PCT/CN2017/073868 patent/WO2017140253A1/zh not_active Ceased
- 2017-02-18 TW TW106105458A patent/TWI732822B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP3417857A4 (en) | 2019-10-23 |
| RU2018129762A (ru) | 2020-03-19 |
| CN107530325A (zh) | 2018-01-02 |
| CA3014088A1 (en) | 2017-08-24 |
| HK1244703A1 (zh) | 2018-08-17 |
| JP2019505526A (ja) | 2019-02-28 |
| MX2018009742A (es) | 2018-11-09 |
| EP3417857A1 (en) | 2018-12-26 |
| WO2017140253A1 (zh) | 2017-08-24 |
| CN107530325B (zh) | 2021-02-23 |
| BR112018015370A2 (pt) | 2018-12-18 |
| JP6968075B2 (ja) | 2021-11-17 |
| EP3417857B1 (en) | 2023-07-19 |
| AU2017220970A1 (en) | 2018-08-02 |
| KR20180109991A (ko) | 2018-10-08 |
| RU2018129762A3 (es) | 2020-03-19 |
| RU2749135C2 (ru) | 2021-06-04 |
| US10588978B2 (en) | 2020-03-17 |
| AU2017220970B2 (en) | 2021-12-16 |
| TW201729805A (zh) | 2017-09-01 |
| TWI732822B (zh) | 2021-07-11 |
| US20190038755A1 (en) | 2019-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3651766T3 (da) | 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-l-yl)-3-fluorbenzonitril som antiproliferativ forbindelse | |
| UA122520C2 (uk) | Кристалічна форма 2-[4-(4-хлорфенокси)-2-(трифторметил)феніл]-1-(1,2,4-триазол-1-іл)пропан-2-олу, агрохімічна композиція, застосування та спосіб боротьби зі шкідливими грибами | |
| EP2883875A4 (en) | N2, N4-BIS (4- (PIPERAZINE-1-YL) PHENYL) PIRIMIDINE-2,4-DIAMINE DERIVATIVE OR PHARMACEUTICALLY UNINTENTIONAL SALT AND COMPOSITION THEREOF AS ACTIVE AGENT FOR THE PREVENTION OR TREATMENT OF CANCER | |
| MX2022004992A (es) | Uso de compuestos de 3-isoxazolidinonas como herbicidas selectivos. | |
| HUE047666T2 (hu) | Eljárás 2-[4-(4-Klórfenoxi)-2-(trifluormetil)fenil]-1-(1,2,4-triazol-1-il)-2-propanol elõállítására | |
| IL266522B1 (en) | 2-) and in the solid state of 3,3,3,1,1,1-hexafluoropropane-2-yl-4 n a medicinal preparation in water zyl)piperazine-1-carboxylate (pyrrolidine-1-yl)-4-(trifluoromethyl | |
| IL252368B (en) | 2-(5,1-dimethyl-3-phenyl-h1-pyrrol-2-yl)-n-(4-(4-(5-fluoropyrimidin-2-yl)piperazin-1-yl)phenyl)-2- Oxacetamide and pharmaceutical preparations containing it | |
| LT3644999T (lt) | 2-(4-chlorfenil)-n-((2-(2,6-dioksopiperidin-3-il)-1-oksoizoindolin-5-il) metil)-2,2-difluoracetamido kompozicijos ir panaudojimo būdai | |
| MX385964B (es) | Formas sólidas de 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolin-5-il) metil)-2,2-difluoroacetamida y sus composiciones farmacéuticas y usos. | |
| EP3735243A4 (en) | ISOTOPOLOGISTS OF 2- (4-CHLOROPHENYL) -N - ((2- (2,6-DIOXOPIPERIDIN-3-YL) -1-OXOISOINDOLIN-5-YL) METHYL) -2,2-DIFLUOROACETAMIDE | |
| ZA201804482B (en) | Formulations of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide | |
| PL3464276T3 (pl) | Nowa postać krystaliczna n-[5-(3,5-difluoro-benzylo)-1h-indazol-3-ilo)-4-(4-metylopiperazyn-1-ylo)-2-tetrahydropiran-4-yloamino)-benzamidu | |
| IL284680A (en) | Solid forms comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl) benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof, and compositions comprising and methods of using the same | |
| ZA201901308B (en) | Aqueous 2-(2,4-dichlorophenyl)methyl -4,4-dimethyl-3-isoxazolidinone-based capsule suspension concentrates | |
| IL284509A (en) | Compounds and methods of use of 2-(4-chlorophenyl)-N-((2-(26-deoxypyricin-3-yl)-1-(oxoisoindolin-5-yl)meranyl)-2,2-difluoroacetamide | |
| EP4054578A4 (en) | COMBINATION THERAPY WITH 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDINE-3-YL)-1-OXOISOINDOLINE-5-YL) METHYL)-2,2-DIFLUOROACETAMIDE | |
| SI3672571T1 (sl) | Farmacevtska vodna raztopina, ki vsebuje 1-(4-((4-(dimetilamino) piperdin-1-il)karbonil)fenil)-3-(4-(4,6-dimorfolin-4-il-1,3, 5-triazin-2-il)fenil)sečnino | |
| MA35636B1 (fr) | Formulation à libération immédiate de 4-méthyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-[5-(4-méthyl- 1h-imidazol-1-yl)-3-(trifluorométhyl)phényl]benzamide | |
| EP3150587A4 (en) | Deuterium substituted 1-[2-(2,4-dimethyl-thiophenyl)-phenyl]piperazine compound or derivative thereof, and pharmaceutical composition and use thereof | |
| IL284665B1 (en) | Pharmaceutical compounds consisting of (S) –4– (4– (4 – (((2– (2,6–dioxopyridin–3–yl) –1–oxoisinolin–4–yl)oxy) METYL) BENZYL) PIPERAZIN–1– YL) –3–FLUOROBENZONITRILE and methods of use thereof | |
| MX2017008077A (es) | Composiciones de (s)-n-(3-(6-isopropoxipiridin-3-il)-1h-indazol-5- il)-1-(2-(4-(4-(1-metil-1h-1,2,4-triazol-3-il)fenil)-3,6-dihidrop iridin-1(2h)-il)-2-oxoetil)-3-(metiltio)pirrolidin-3-carboxamida para preparaciones farmaceuticas. | |
| AR111255A1 (es) | Derivados de 4-piperidin-n-(pirimidin-4-il)croman-7-sulfonamidas inhibidores de canales de sodio | |
| MX2018009742A (es) | "composicion farmaceutica que contiene un derivado de imidazolina". | |
| EP3233079A4 (en) | (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations | |
| MX2018005251A (es) | Inhibidor del receptor p2x7. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |